Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ASTELLAS US LLC et al v. SAGENT PHARMACEUTICALS, INC. et al
Case Number:
3:11-cv-03533
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 12, 2011
Astellas Settles Patent Suit Over Generic Adenoscan
Astellas Pharma US Inc. settled a lawsuit Monday in New Jersey that accused generics makers Sagent Pharmaceuticals Inc. and Strides Arcolab Ltd. of violating its patent covering pharmacologic stress agent Adenoscan.
-
June 21, 2011
Astellas Hits Sagent, Strides With Adenoscan IP Suit
Astellas Pharma US LLC and affiliate Item Development AB hit Sagent Pharmaceuticals Inc. and Strides Arcolab Ltd. with a lawsuit in New Jersey federal court on Tuesday for allegedly violating a patent for the pharmacologic stress agent Adenoscan.